WHO ICTRP trial

An open-label, randomized, two-period crossover study to compare the…

JPRN-UMIN000018040 · Japan Primary Registries Network (JPRN) · Not Recruiting

Key facts

Trial ID JPRN-UMIN000018040
Public title An open-label, randomized, two-period crossover study to compare the pharmacokinetic and safety profile of single dose of TAK-070 (50 mg) under fed and fasting condition in healthy volunteer
Scientific title An open-label, randomized, two-period crossover study to compare the pharmacokinetic and safety profile of single dose of TAK-070 (50 mg) under fed and fasting condition in healthy volunteer - An open-label, randomized, study to compare the pharmacokinetic and safety profile of single dose of…
Primary sponsor Unit for Early and Exploratory Clinical Development, The University of Tokyo Hospital
Registry Japan Primary Registries Network (JPRN)
Recruitment status Not Recruiting
Study type Interventional
Phase Phase I
Countries Japan
Conditions Alzheimer's disease
Interventions Fasted single dosing of TAK-070 50mg followed by fed single dosing of TAK-070 50mg Fed single dosing of TAK-070 50mg followed by fasted single dosing of TAK-070 50mg
Registration date Jun 23, 2015
Target size 8
Registry page center6.umin.ac.jp

At a glance

  • No Results available

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About WHO ICTRP trial registrations

The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.

Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date:

Browse all WHO ICTRP trial registrations